Published in Br Med J on October 25, 1975
Chromogranin-reactive endocrine cells in argyrophilic carcinomas ("carcinoids") and normal tissue of the breast. Am J Pathol (1985) 1.03
Epidermal proliferation of nude mouse skin, pig skin, and pig skin grafts. Failure of nude mouse skin to respond to the tumor promoter 12-O-tetradecanoyl phorbol 13-acetate. J Exp Med (1980) 0.94
Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives. Oncologist (2015) 0.85
Autoradiographic studies of cell dynamics in immunogenic granulomas transplanted into the skin of athymic nude mice. Arch Dermatol Res (1985) 0.76
A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol (1972) 2.76
Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet (1974) 2.30
Radio-immunoassay of casein in the serum of normal subjects and of patients with various malignancies. Eur J Cancer (1974) 1.38
IDENTIFICATION OF INSULIN AND GLUGACON IN A BRONCHOGENIC METASTASIS. J Clin Endocrinol Metab (1964) 1.24
Evaluation of carcinoembryonic antigen in human mammary carcinoma. J Natl Cancer Inst (1973) 1.21
Ectopic secretion of calcitonin by oat-cell carcinoma. N Engl J Med (1974) 1.09
Evidence for a pro-calcitonin. Biochem Biophys Res Commun (1974) 1.01
Concentrations of calcitonin and catecholamines in pheochromocytomas, a mucosal neuroma and medullary thyroid carcinoma. J Clin Endocrinol Metab (1973) 0.92
Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma. Br Med J (1972) 5.48
A shorter immunoperoxidase technique for the demonstration of carcinoembryonic antigen and other cell products. J Clin Pathol (1977) 3.77
Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet (1999) 3.50
Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. Lancet (1980) 2.82
Surgical site infection after groin hernia repair. Br J Surg (2004) 2.54
Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. Br J Cancer (1972) 2.53
The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections. Br J Cancer (1980) 2.50
Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet (1974) 2.30
A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line. Eur J Immunol (1982) 2.17
Clinical and economic benefits of ramipril: an Australian analysis of the HOPE study. Intern Med J (2003) 2.16
Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res (2001) 2.15
Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer (1992) 2.10
Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist. Lancet (1987) 2.09
Detection of micrometastases in patients with primary breast cancer. Lancet (1983) 2.07
Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res (1982) 2.07
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route. Cancer Res (1987) 2.03
Isolation and characterization of human calcitonin gene-related peptide. Nature (1984) 2.03
Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin. Lancet (1976) 1.92
Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour. Lancet (1970) 1.90
Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet (1980) 1.88
Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc Natl Acad Sci U S A (2001) 1.87
Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res (1994) 1.84
Biochemical monitoring of cancer. A review. Ann Clin Biochem (1976) 1.83
Affinity of calciferol analogues for 25-hydroxycholecalciferol receptors. Clin Sci Mol Med (1974) 1.83
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy (1999) 1.83
The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer. Br J Cancer (1973) 1.81
Survey of treatment of primary breast cancer in Great Britain. Br Med J (Clin Res Ed) (1985) 1.80
Estrogen receptor alpha in human breast cancer: occurrence and significance. J Mammary Gland Biol Neoplasia (2000) 1.79
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol Cell (2000) 1.77
Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer (1983) 1.73
Diagnosing breast carcinoma in young women. BMJ (1991) 1.71
Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck. Br J Cancer (1981) 1.70
Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J (1974) 1.69
Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues. Virchows Arch A Pathol Anat Histol (1982) 1.68
Co-localization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs. Neurosci Lett (1985) 1.66
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
Cancer-testis antigen expression in triple-negative breast cancer. Ann Oncol (2010) 1.65
Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization. Mol Cell Biol (1999) 1.60
Hypercalcaemia in rheumatoid arthritis: investigation of its causes and implications. Ann Rheum Dis (1979) 1.58
Are breast cancer axillary node micrometastases worth detecting? J Pathol (1990) 1.57
Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci U S A (2001) 1.55
Retracted Altered calcitonin gene in a young patient with osteoporosis. BMJ (1989) 1.55
Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther (1981) 1.52
Estrogen and progesterone receptors in the normal female breast. Cancer Res (1991) 1.50
Biochemical markers in human breast cancer. Lancet (1977) 1.48
Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet (1981) 1.47
Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions. J Clin Pathol (1981) 1.46
A physiological role for calcitonin: protection of the maternal skeleton. Lancet (1979) 1.44
Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem (1997) 1.42
Physical test for distant metastases in patients with breast cancer. J R Soc Med (1980) 1.42
Estrogen receptor beta in breast cancer. Endocr Relat Cancer (2002) 1.41
Potential pathological application of immunocytochemical methods to the detection of micrometastases. Cancer Res (1980) 1.41
Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer (1981) 1.39
Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy. J Clin Oncol (1986) 1.39
Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J (Clin Res Ed) (1987) 1.36
Intrathoracic phaeochromocytoma. Br J Surg (1970) 1.36
Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet (1989) 1.36
4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer. Lancet (1984) 1.35
Carcinoembryonic antigen in the urine of patients with urothelial carcinoma. Br Med J (1972) 1.34
FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance. Oncogene (2010) 1.34
Studies on carcinoembryonic antigen (CEA) and a related glycoprotein, CCEA-2. Preparation and chemical characterisation. Immunochemistry (1973) 1.34
Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment. Br J Cancer (2008) 1.34
Isolation of pure populations of epithelial and myoepithelial cells from the normal human mammary gland using immunomagnetic separation with Dynabeads. Anal Biochem (1995) 1.33
Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. J Clin Oncol (2000) 1.33
Morphological responses to corticotrophin and cyclic AMP by adult rat adrenocortical cells in monolayer culture. J Endocrinol (1973) 1.31
Transplantation of human tumour to immune deprived mice treated with anti-thymocyte serum. Br J Cancer (1973) 1.30
Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet (1999) 1.28
Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients. Br J Cancer (2012) 1.27
Aminoglutethimide in treatment of metastatic breast carcinoma. Lancet (1978) 1.27
The human mammary gland basement membrane is integral to the polarity of luminal epithelial cells. Exp Cell Res (1999) 1.26
Inhibition of gamma-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells. Br J Cancer (2009) 1.25
Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodies. Br J Cancer (1981) 1.24
Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes. Br J Cancer (1977) 1.24
Growth factor expression in normal, benign, and malignant breast tissue. Br Med J (Clin Res Ed) (1988) 1.24
Monoclonal antibodies and human tumor pathology. Hum Pathol (1982) 1.24
The pathology of the adrenal gland in Cushing's syndrome. J Pathol Bacteriol (1967) 1.23
Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur J Cancer (1991) 1.23
Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab (1988) 1.22
CEA, ZGM and EMA localization in cells of pleural and peritoneal effusion: a preliminary study. Invest Cell Pathol (1981) 1.22
Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus. J Biol Chem (1995) 1.22
Effect of PUVA on serum 25-OH vitamin D in psoriatics. Br Med J (1979) 1.21
Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients. Cancer Res (1989) 1.21
Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression. Endocr Relat Cancer (2006) 1.20
Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur J Surg Oncol (1994) 1.19
The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer. Oncogene (2009) 1.19
Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol (1999) 1.19
Detection of HER2 amplification in circulating free DNA in patients with breast cancer. Br J Cancer (2011) 1.19
A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer. Br J Cancer (1998) 1.19
The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer (1997) 1.18